The CDC this week noted what providers and parents have been seeing across the country: rising cases of a non-polio enterovirus causing severe respiratory illness and acute flaccid myelitis (AFM).
Providers should be aware of enterovirus D68 (EV-D68) causing severe respiratory illness and acute flaccid myelitis (AFM) in children and adolescents, the CDC said this week, saying that infections are rising across the country.
EV-D68 is one of more than 100 non-polio enteroviruses; it often arrives as summer turns to fall and can causes respiratory illness similar to a mild cold, or it may become more severe. It causes about 15 million infections a year in the United States.
It can also lead to AFM, with weakness and paralysis of the arms and legs. Past outbreaks of EV-D68 and AFM were seen in 2014, 2016, and 2018.
However, disease activity was low during the COVID-19 pandemic in 2020 and 2021. Over the past few weeks, news reports began popping up of children heading to the emergency department (ED) or being hospitalized with acute respiratory illness and asthma/reactive airway disease.
Surveillance data released Tuesday bore those reports out. The data shows that positive test results for rhinovirus/enterovirus “appears to be increasing at a rate comparable to that in past EV-D68 outbreak years,” doubling in a period of a few weeks through early September, the CDC said.
“Clinicians are advised to consider EV-D68 as a possible cause of severe respiratory illness in children and adolescents, particularly those with wheezing or who require respiratory support,” the CDC said.
In addition to testing for AFM, health care providers are urged to test for poliovirus, which has been found in New York wastewater.
What Will AI in Health Care Look Like in the Future?
July 10th 2025Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and shaping future health care training, as discussed by experts at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen